An aggressive subtype of B-CLL is characterized by strong CD44 expression and lack of CD11c

British Journal of Haematology

Volumn 93, Issue 3, 1996, Pages 661-669

  Eisterer, Wolfgang ^a   Hilbe, Wolfgang ^a   Stauder, Reinhard ^a,b   Bechter, Oliver ^a   Fend, Falko ^c   Thaler, Josef ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b BASEL INSTITUTE FOR IMMUNOLOGY   (Switzerland)

^c UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

B CLL; CD44; Prognosis; 2 integrins

Indexed keywords

GLYCOPROTEIN P 15095; HERMES ANTIGEN; INTEGRIN;

ADULT; AGED; ARTICLE; B CELL LEUKEMIA; CHRONIC LYMPHATIC LEUKEMIA; FEMALE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS;

EID: 0029924828     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1996.d01-1704.x     Document Type: Article

References (60)

1. Arnaout, M.A. (1990) Structure and function of the leukocyte adhesion molecules CD11/CD18. Blood, 75, 1037-1050.
2. Baldini, L., Cro, L., Calori, R., Nobili, L., Silvestris, I. & Maiolo, A.T. (1992) Differential expression of very late activation antigen-3 (VLA-3)/VLA-4 in B-cell non-Hodgkin lyphoma and B-cell chronic lymphocytic leukemia. Bloos, 79, 2688-2693.
3. Binet, J.L., Auquier, A., Dighiero, G., Chastang, C. Piguet, H., Goasguen, J., Vaugier, G., Potron, G., Colona, P., Thomas, M., Tchernia, G., Jacquillat, C., Boivin, P., Lesty, C., Duault, M.T. & Montconduit, M. (1981) A new prognostic classification of chronic lymphocytic leukemia derived from multivariate survival analysis. Cancer, 48, 198-206.
4. Boyd, A.W., Dunn, S.M., Fecondo, J.V., Culvenor, J.G., Dührsen, U., Burns, G.F. & Wawryk, S.O. (1989) Regulation of expression of a human intercellular adhesion molecule (ICAM-1) during lymphohematopoietic differentiation. Blood, 73, 1896-1903.
5. Boyd, A.W., Wawryk, S.O., Burns, G.F. & Fecondo, J.V. (1988) Intercellular adhesion molecule I (ICAM-1) has a central role in cell-cell contact-mediated immune mechanisms. Proceedings of the National Academy of Sciences of the United States of America, 85, 3095-3099.
6. Caligaris-Cappio, F., Bergui, L., Schena, M., Chilosi, M. & Marchisso, P.C. (1989) Cell-cell and cell-matrix adhesion structures may influence the growth pattern of chronic lymphoid malignancies, Leukemia, 3, 167-172.
7. Cox, D.R. (1972) Regression models and life tables. Journal of the Royal Statistical Society B, 54, 187-220.
8. Dadmarz, R. & Cawley, J.C. (1988) Heterogeneity of CLL: high CD23 antigen and aIFN receptor expression are features of favourable disease and of cell activation. British Journal of Haematology, 68, 279-282.
9. De Rossi, G., Tenca, C., Cerruti, G., Favre, A., Zarcone, D., Tabilio, A., Mauro, F.R., Annino, L. & Grossi, C.E. (1994) Adhesion molecule expression on B-cells from acute and chronic lymphoid leukemias. Leukemia and Lymphoma, 16, 31-36.
10. De Rossi, G., Zarcone, D., Mauro, F., Cerruti, G., Tenca, C., Puccetti, A., Mandelli, F. & Grossi, C.E. (1995) Adhesion molecule expression on B-cell chronic lymphocytic leukemia cells: malignant phenotypes define distinct disease subsets. Blood, 81, 2679-2687.
11. Drexler, H.G. (1986) Classification of acute myeloid leukemias: a comparison of FAB and immunophenotyping. Leukemia, 1, 697-705.
12. Eisterer, W., Hilbe, W., Fend, F., Ludescher, C., Falk, M. & Thaler, J. (1995) Identification of a favorable subgroup of patients with generalized immunocytomas by follicular dendritic cells. Leukemia, 9, 254-259.
13. Erikstein, B.K., Holte, H., Kvaloy, S., Andersson, K.B., Steeu, H.B., Hannisdal, E. & Smeland, E.B. (1995) Expression of CD18 (integrin b2 chain) correlates with prognosis in malignant B-cell lymphomas. British Journal of Haematology, 83, 392-398.
14. French Cooperative Group on Chronic Lymphocytic Leukaemia (1990) Natural history of stage A chronic lymphocytic leukaemia untreated patients. British Journal of Haematology, 76, 45-57.
15. Geisler, C., Larsen, J. & Hansen, N. (1991) Prognostic importance of flow cytometric immunophenotyping of 540 consecutive patients with B-cell chronic lymphocytic leukemia. Blood, 78, 1795-1802.
16. Griffin, J.D., Davis, R., Nelson, D.A., Davey, F.R., Mayer, R.J., Schiffer, C., McIntyre, O.R. & Bloomfield, C.D. (1986) Use of surface marker analysis to predict outcome of adult acute myetoblastic leukemia. Blood, 68, 1232-1241.
17. Günthert, U., Hofmann, M., Rudy, W., Reber, S., Zöller, M., Haubmann, I., Matzku, S., Wenzel, A., Ponta, H. & Herrlich, P. (1991) A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell, 65, 13-24.
18. Günther, U., Stauder, R., Mayer, B., Terpe. H.J., Finke, L. & Friedrichs, K. (1995) Are CD44 variant isoforms involved in human tumour progression? Cancer Surveys, 24, 19-42.
19. Hanson, C.A., Gribbin, T.E., Schnitzer, B., Schlegelmilch, J.A., Mitchell, B.S. & Stoolman, L.M. (1990) CD11c (Leu-M5) expression characterizes a B-cell chronic lymphoproliferative disorder with features of both chronic lymphocytic leukemia and hairy cell leukemia. Blood, 76, 2360-2367.
20. Harris, N.L., Jaffe, E.S., Stein, H., Banks, P.M., Chan, J.K.C., Cleary, M.L., Delsol, G., De Wolf-Peeters, C., Failini, B., Gatter, K.C., Grogan, T.M., Isaacson, P.G., Knowles, D.M., Mason, D.Y., Müller-Hermelink, H.K., Pileri, S.A., Piris, M.A., Ralfkiaer, E. & Warnke, R.A. (1994) A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood, 84, 1361-1392.
21. Horst, E., Meijer, C.J.L.M., Radaskiewicz, T., Ossekoppele, G.J., Van Krieken, J.H.J.M. & Pals, S.T. (1990) Adhesion molecules in the prognosis of diffuse large-cell lymphoma: expression of lymphocyte homing reeeplor (CD44), LFA-1 (CD11a/181, and ICAM-1 (CD54). Leukemia, 4, 595-599.
22. Hynes, R.O. (1992) Integrins: versatility, modulation, and signaling in cell adhesion. Cell, 69, 11-25.
23. Inghirami, G., Wiezorek, R., Zhu, B.Y., Silber, R., Dalla-Favera, R. & Knowles, D.M. (1988) Differential expression of LFA-1 molecules in non-Hodgkin's lymphoma and lymphoid leukemia. Blood. 72, 1431-1434.
24. Jalkanen, S., Aho, R., Kallajoki, M., Ekfors, T., Nortamo, P., Gahmberg, C., Duijvestijn, A. & Kalimo, H. (1989) Lymphocyte homing receptors and adhesion molecules in intravascular malignant lymphomatosts. International Journal of Cancer, 44, 777-782.
25. Jalkanen, S., Joennsuu, H. & Klemi, P. (1990) Prognostic value of lymphocyte homing receptor and S phase fraction in non-Hodgkin's lymphoma. Blood, 75, 1549-1556.
26. Jalkanen, S., Joensuu, H., Söderström, K.O. & Klemi, P. (1991) Lymphocyte homing and clinical behavior of non-Hodgkin's lymphoma. Journal of Clinical Investigation, 87, 1835-1840.
27. Joensuu, H., Ristamäki, R., Klemi, P.J. & Jalkanen, S. (1993) Lymphocyte homing receptor (CD44) expression is associated with poor prognosis in gastrointestinal lymphoma. British Journal of Cancer, 68, 428-432.
28. Kaplan, E.L. & Meier, P. (1958) Nonparametric estimation for incomplete observations. Journal of the American Statistical Association, 53, 457-481.
29. Kurec, A.S., Threatte, G.A., Gottlielo, A.J., Smith, J.R. & Davey, F.R. (1992) Immunophenotypic subclassification of chronic lymphocytic leukaemia (CLL). British Journal of Haematology, 81, 45-51.
30. Lee, J.S., Dixon, D.O., Kantarjian, H.M., Keating, M.J. & Talpaz, M. (1987) Prognosis of chronic lymphocytic leukemia: a multivariate regression analysis of 325 untreated patients. Blood, 69, 929-936.
31. Lennert, K. & Feller, A.C. (1992) Histopathology of Non-Hodgkin's Lymphomas according to the Updated Kiel Classification, Springer, Paris.
32. Lesley, J., Hyman, R. & Kincade, P.W. (1995) CD44 and its interaction with extracellular matrix. Advances in Immunology, 54, 271-335.
33. Lokhorst, H.M., Lamme, T., De Smet, M., Klein, S., De Weger, R.A., Van Oers, R. & Bloem, A.C. (1994) Primary tumor cells of myeloma patients induce interleukin-6 secretion in long-term bone marron cultures. Blood, 84, 2269-2277.
34. Mackay, C.R., Maddox, J.F., Wijffels, G.L., Mackay, R. & Walker, I.D. (1988) Characterization of a 95000 molecule on sheep leucocytes homologous to murine Pgp-1 and human CD44. Immunology, 65, 95.
35. Mackay, C.R., Terpe, H.J., Stauder, R., Marston, W.L., Stark, H. & Günthert, U. (1994) Expression and modulation of CD44 variant isoforms in humans. Journal of Cell Biology, 124, 71-82.
36. Maio, M., Pinto, A., Carbone, A., Zagonel, V., Gloghini, A., Marotta, G., Cirillo, D., Colombatti, A., Ferrara, F., DelVecchio, L. & Ferrone, S. (1990) Differential expression of CD54/intercellular adhesion molecule-1 in myeloid leukemias and in lymphoproliferative disorders, Blood, 76, 783-790.
37. Makgoba, M.W., Sanders, M.E., Luce, G.E.G., Dustin, M.L. Springer, T.A., Clark, E.A., Mannoni, P. & Shaw, S. (1988) ICAM-1, the ligand for LFA-1 dependent adhesion of B. T. and myeloid cells. Nature, 331, 86-88.
38. Molica, S. (1991) Progression and survival studies in early chronic lymphocytic leukemia. Blood, 78, 895-899.
39. Montserrat, E., Sanchez-Bisono, J., Vinolas, N. & Rozman, C. (1986) Lymphocyte doubling time in chronic lymphocytic leukemia: analysis of its prognostic significance. British Journal of Haematology, 62, 567-575.
40. Newman, R.A., Peterson, B., Davey, F.R., Brabyn, C., Collins, H., Brunetto, V.L., Duggan, D.B., Weiss, R.B., Royston, I., Millard, F.E., Miller, A.A. & Bloomfield, C.D. (1993) Phenotypic markers and BCL-1 gene rearrangements in B-cell chronic lymphocytic leukemia: a Cancer and Leukemia Group B study. Blood, 82, 1239-1246.
41. Orfao, A., Gonzalez, M., San Miguel, J.F., Rios, A., Canizo, M.C., Hernandez, J., Maricato, M.L. & Borrasca, A.L. (1989) B-cell chronic lymphocytic leukemia: prognostic value of the immunephenotype and the clinico-hematological features. American Journal of Hematology, 31, 26-31.
42. Pals, S.T., Horst, E., Ossekoppele, G.J., Figdor, C.G., Scheper, R.J. & Meijer, C.J.L.M. (1989) Expression of lymphocyte homing receptor as a mechanism of dissemination in non-Hodgkin's lymphoma. Blood, 73, 885-888.
43. Palutke, M., Tabaczka, P. & Gingrich, D. (1992) CD11c expression in chronic lymphocytic leukemia. Blood, 80, 2685.
44. Pangalis, G.A., Boussiotis, V.A. & Kittas, C. (1988) B-chronic lymphocytic leukemia: disease progression in 150 untreated stage A and B patients as predicted by bone marrow pattern. Nouvelle Revue Française d'Hématologie, 30, 373-375.
45. Picker, L.J., Medeiros, L.J., Weiss, L.M., Warnke, R.A. & Butcher, E.C. (1988) Expression of lymphocyte homing receptor antigen in non-Hodgkin's lymphoma. American Journal of Pathology, 130, 496-504.
46. Rai, K.R., Sawitsky, A. & Cronkite, E.P. (1975) Clinical staging of chronic lymphocytic leukemia. Blood, 46, 219.
47. Roossien, F.F., De Rijk, D., Bikker, A. & Roos, E. (1989) Involvement of LFA-1 in lymphoma invasion and metastasis demonstrated with LFA-1-deficient mutants. Journal of Cell Biology, 108, 1979-1985.
48. Rothlein, R., Dustin, M.L., Marlin, S.D. & Springer, T.A. (1986) A human intercellular adhesion molecule (ICAM-1) distinct from LFA-1. Journal of Immunology, 137, 1270-1274.
49. Rozman, C., Montserrat, E., Rodriguez-Fernandez, J.M., Ayats, R., Vallespi, T., Parody, R., Rios, A., Prados, D., Morey, M., Gomis, F., Alcala, A., Gutierrez, M., Maldonado, J., Gonzalez, C., Giralt, M., Hernandez-Nieto, L., Cabrera, A. & Fernandez-Ranada, J.M. (1984) Bone marrow histologic pattern the best single prognostic parameter in chronic lymphocytic leukemia: a multivariate analysis of 329 cases. Blood, 3, 642-648.
50. Ruoslahti, E. & Giancotti, F. (1989) Integrins and tumor cell dissemination. Cancer Cells, 1, 119-126.
51. Schultz, T.F., Vogetseder, W., Mitterer, M., Neumayer, H.P., Myones, B.L., Stauder, R., Greil, R., Böck, G., Feichtinger, H., Huber, H. & Dierich, M.P. (1988) Importance of an 85kDa membrane glycoprotein for a variety of cell-cell interactions. Molecular Immunology, 11, 1053-1061.
52. Springer, T.A. (1994) Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell, 76, 301-314.
53. Stauder, R., Eisterer, W., Thaler, J. & Günthert, U. (1995) CD44 variant isoforms in non-Hodgkin's lymphoma: a new independent prognostic factor. Blood, 85, 2885-2899.
54. Stauder, R., Greil, R., Schulz, T.F., Thaler, J., Gattringer, C., Radaskiewcz, T., Dierich, M.P. & Huber, H. (1989) Expression of leucocyte function-associated antigen-1 and 7F7-antigen, an adhesion molecule related to intercellular adhesion molecule-1 (ICAM-1) in non-Hodgkin lymphomas and leukaemias: possible influence on growth pattern and leukaemic behaviour. Clinical and Experimental Immunology, 77, 234-238.
55. Stauder, R.& Günthert, U. (1995) CD44 isoforms - impact on lymphocyte activation and differentiation. The Immunologist, 3, 26-31.
56. Stauder, R., Hamader, S., Fasching, B., Kemmler, G., Thaler, J. & Huber, H. (1993) Adhesion to high endothelial venules: a model for dissemination mechanisms in non-Hodgkin's lymphoma. Blood, 82, 262-267.
57. Tassies, D., Montserrat, E., Villamor, N. & Rozman, C. (1991) CD11c positive B-chronic lymphocytic leukemia. Blood, 78, 1893.
58. Terpe, A., Koopmann, R., Imhof, B. & Günthert, U. (1994) Expression of integrins and CD44 in non-Hodgkin's lymphomas: CD44 variants are preferentially expressed in high-grade malignant lymphomas. Journal of Pathology, 101, 79-94.
59. Thaler, J., Denz, H., Gattringer, C., Glassl, H., Lechleitner, M., Dietze, O. & Huber, H. (1987) Diagnostic and prognostic value of immunohistological bone marrow examination: results in 212 patients with lymphoproliferative disorders. Blut, 54, 213-222.
60. + chronic B-cell leukemias and the identification of novel peripheral blood B-cell subsets with chronic lymphoid leukemia immunophenotypes. Blood, 76, 123-130.